United Therapeutics Corporation - Common Stock (NQ:UTHR)
548.73
-7.18
(-1.29%)
Streaming Delayed Price
Updated: 12:09 PM EDT, Jul 6, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 82,475 |
| Open | 556.31 |
| Bid (Size) | 548.63 (40) |
| Ask (Size) | 549.97 (160) |
| Prev. Close | 555.91 |
| Today's Range | 546.99 - 556.45 |
| 52wk Range | 272.12 - 609.35 |
| Shares Outstanding | 44,891,523 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
2 Mid-Cap Stocks on Our Buy List and 1 We Turn Down
May 29, 2026
UTHR Q1 2026 Earnings Transcript ↗
May 06, 2026
Frequently Asked Questions
Is United Therapeutics Corporation - Common Stock publicly traded?
Yes, United Therapeutics Corporation - Common Stock is publicly traded.
What exchange does United Therapeutics Corporation - Common Stock trade on?
United Therapeutics Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for United Therapeutics Corporation - Common Stock?
The ticker symbol for United Therapeutics Corporation - Common Stock is UTHR on the Nasdaq Stock Market
What is the current price of United Therapeutics Corporation - Common Stock?
The current price of United Therapeutics Corporation - Common Stock is 548.73
When was United Therapeutics Corporation - Common Stock last traded?
The last trade of United Therapeutics Corporation - Common Stock was at 07/06/26 12:09 PM ET
What is the market capitalization of United Therapeutics Corporation - Common Stock?
The market capitalization of United Therapeutics Corporation - Common Stock is 24.63B
How many shares of United Therapeutics Corporation - Common Stock are outstanding?
United Therapeutics Corporation - Common Stock has 25B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.